APA (7th ed.) Citation

Tereshchenko, S. N., Glezer, M. G., Abugov, S. A., Averkov, O. V., Antipov, S. I., Galyavich, A. S., . . . Yakushin, S. S. (2019). Place of Prasugrel, P2Y12 receptor antagonist, in an early invasive treatment of patients with acute coronary syndrome (according to the results of multicenter randomized controlled trial ISAR-REACT 5). «FIRMA «SILICEA» LLC.

Chicago Style (17th ed.) Citation

Tereshchenko, S. N., et al. Place of Prasugrel, P2Y12 Receptor Antagonist, in an Early Invasive Treatment of Patients with Acute Coronary Syndrome (according to the Results of Multicenter Randomized Controlled Trial ISAR-REACT 5). «FIRMA «SILICEA» LLC, 2019.

MLA (9th ed.) Citation

Tereshchenko, S. N., et al. Place of Prasugrel, P2Y12 Receptor Antagonist, in an Early Invasive Treatment of Patients with Acute Coronary Syndrome (according to the Results of Multicenter Randomized Controlled Trial ISAR-REACT 5). «FIRMA «SILICEA» LLC, 2019.